Deutsche Bank initiated coverage on DocGo with a new price target
$DCGO
Medical/Nursing Services
Health Care
Deutsche Bank initiated coverage of DocGo with a rating of Buy and set a new price target of $11.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/18/2023 | $15.00 | Buy | BTIG Research |
| 4/21/2023 | $11.00 | Overweight | Cantor Fitzgerald |
| 4/19/2022 | $11.00 | Buy | Deutsche Bank |
| 1/19/2022 | $14.00 | Buy | Stifel |
| 12/21/2021 | $13.00 | Buy | Canaccord Genuity |
| 12/7/2021 | $14.00 | Buy | Needham |
| 11/30/2021 | $16.00 → $22.00 | Outperform | Northland Capital Markets |
| 11/30/2021 | $14.00 | Overweight | Barclays |
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"),a leading provider of technology-enabled mobile health services, today announced it has secured five new contracts that include remote patient monitoring (RPM), virtual care management (VCM), chronic care management (CCM), cardiac implantable electronic device (CIED), and a care gap closure program for a national health plan. These noteworthy examples of new DocGo contracts expand the Company's reach and ability to deliver quality virtual, in-person, and mobile healthcare services.
BTIG analyst David Larsen maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $11 to $7.
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
Company Significantly Expands Operations on the West Coast to Support New Payer Programs, Increases Full-Year Guidance for Cash Flow from Operations Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenue for the third quarter of 2024 was $138.7 million, compared to $186.6 million in the third quarter of 2023, a decrease of 26%. The decline was primarily due to the planned wind down of migrant-related progra
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the third quarter ended September 30, 2024 after the markets close on Thursday, November 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, November 7, 2024 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) A webcast of the conference call can be accessed under Events on the Investors section of the Company's
Company Raises Cash Flow From Operations Guidance to $80-$90 Million, Reiterates 2024 Revenue Guidance of $600-$650 Million and Adjusted EBITDA1 Guidance of $65-$75 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time (Note Corrected Call Information Below) DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Total revenue for the second quarter of 2024 was $164.9 million, compared to $125.5 million in the second quarter of 2023, an increase of 31%. GAAP gros
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in November: Southwest Ideas Conference (November 20th) Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings, and deliver a presentation on Wednesday November 20th at 5:10 PM ET. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum (November 21st) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings at this event. Contact your Can
Company Significantly Expands Operations on the West Coast to Support New Payer Programs, Increases Full-Year Guidance for Cash Flow from Operations Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenue for the third quarter of 2024 was $138.7 million, compared to $186.6 million in the third quarter of 2023, a decrease of 26%. The decline was primarily due to the planned wind down of migrant-related progra
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the third quarter ended September 30, 2024 after the markets close on Thursday, November 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, November 7, 2024 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) A webcast of the conference call can be accessed under Events on the Investors section of the Company's
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers
DocGo stood out as one of the top companies to meet employee needs. DocGo (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services is pleased to announce that U.S. News & World Report, the global authority in rankings and consumer advice, has named DocGo one of the 2024-2025 Best Companies to Work For. DocGo was rated among the Best Companies to Work For ‑ Northeast on factors contributing to job seekers' decision-making when choosing a workplace that best meets their needs. "A key aspect of DocGo's success is our incredible team of passionate, dedicated professionals, and we're always looking for the best of the best to join us," said Lee Bienstock, CEO of DocGo
BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00
Cantor Fitzgerald initiated coverage of DocGo with a rating of Overweight and set a new price target of $11.00
Deutsche Bank initiated coverage of DocGo with a rating of Buy and set a new price target of $11.00
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
10-Q - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)